Need professional-grade analysis? Visit stockanalysis.com
$40.45M
2.28
N/A
N/A
Lite Strategy, Inc. (LITS) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.19, up 5.31% from the previous close.
Over the past year, LITS has traded between a low of $0.95 and a high of $6.86. The stock has lost 44.7% over this period. It is currently 82.7% below its 52-week high.
Lite Strategy, Inc. has a market capitalization of $40.45M, with a price-to-earnings ratio of 2.28.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Side-by-side comparison against top Healthcare peers.